Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F46ZL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,110
Award facts
- Contract value 100% obligated
- $33,109.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Opdivo 240 mg/24 ml vials, a critical oncology pharmaceutical. This firm fixed-price delivery order carries a ceiling value of $33,109.92 and is scheduled for completion by January 27, 2026. The contract was competitively awarded with no set-aside designation, and fulfillment will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and serves critical healthcare needs for military personnel, veterans, and other federal beneficiaries. The company's demonstrated capability to supply a broad range of pharmaceutical products—from specialty medications and vaccines to brand-name and generic drugs—across multiple therapeutic domains positions it as a key vendor for federal medical procurement. This particular delivery order for Opdivo, an important immuno-oncology treatment, reflects the vendor's role in ensuring continued access to essential cancer therapeutics within the Defense Health System.
Quick answers
Who was awarded contract SPE2DR26F46ZL?
SPE2DR26F46ZL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F46ZL worth?
The government has obligated $33,110 on SPE2DR26F46ZL.
Is contract SPE2DR26F46ZL an order under another contract?
Yes. SPE2DR26F46ZL is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F46ZL competed?
The extent of competition for SPE2DR26F46ZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award